Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ProKidney
ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 27, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
August 09, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
June 17, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
June 11, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
June 10, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
June 10, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
May 21, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
May 10, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
March 25, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Jefferies Biotech on the Bay Summit
February 29, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
November 30, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
November 21, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Third Quarter Financial Results
November 14, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
November 13, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
October 30, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
September 05, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
August 10, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
July 18, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
July 17, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
June 13, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
June 01, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights
May 11, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Present at the BofA Securities Health Care Conference 2023
May 04, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights
March 28, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
March 03, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
January 10, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
November 14, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Upcoming Investor Conferences
November 11, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease
November 03, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.